Phosphorus Dendrimer-Mediated Protein Delivery
Biomacromolecules · 10.08.2026 · 27 (8) · 4955-4971
DOI: 10.1021/acs.biomac.6c01257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomacromolecules, online erschienen am 27.07.2026. Verfasst von Yijun Mei und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Fiber Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Bio…. Hauptthemen laut MEDLINE: Dendrimers, Phosphorus, Proteins, Drug Delivery Systems. Die Arbeit nennt 131 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Basic Research Program of China (973 Program), National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Phosphorus dendrimers represent a next-generation nanoplatform that has garnered increasing attention for delivering diverse protein therapeutics. Compared with conventional organic and inorganic protein carriers, phosphorus dendrimers possess distinct advantages, including intrinsic bioactivity, well-defined molecular architecture, multimodal protein-loading mechanisms, considerable structural modifiability, reliable stability, and desired biocompatibility, realizing simple and mild protein complexation merely through physical interactions to construct phosphorus dendrimer-based protein nanomedicines. Recent studies have demonstrated the synergistic therapeutic enhancement against multiple diseases, such as osteoarthritis, cancer, ischemic stroke, Alzheimer’s disease, and Parkinson’s disease, based on these nanomedicines. In this Perspective, the primary synthesis routes of phosphorus dendrimers are systematically outlined at first, and their superiority as protein nanoplatforms over other carriers is comparatively analyzed. Then, the latest advances of the above nanomedicines in disease therapies are summarized in detail, and the current challenges hindering their applications from bench to bedside are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Fiber Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai2…
- CQM-Centro de Química da Madeira, China-Portugal Joint Laboratory of Innovative Nanomedicine, Universidade da Madeira, Campus Universitário da Penteada, 9020-105Funchal, Portugal.
- Centre d'Etudes et de Recherche sur le Medicament de Normandie (CERMN), Université de Caen Normandie, Caen14032, France.
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077Toulouse CEDEX 4, France.
- Université de Toulouse, UPS, INPT, 31077Toulouse CEDEX 4, France.
ORCID-Profile: Yijun Mei, Serge Mignani, Jean-Pierre Majoral, Mingwu Shen, Xiangyang Shi
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Basic Research Program of China (973 Program)
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Mei, Y., Cao, Y., Mignani, S., Majoral, J. P., Shen, M., & Shi, X. (2026). Phosphorus Dendrimer-Mediated Protein Delivery. Biomacromolecules, 27(8), 4955-4971. https://doi.org/10.1021/acs.biomac.6c01257
Vancouver
Mei Y, Cao Y, Mignani S, Majoral JP, Shen M, Shi X. Phosphorus Dendrimer-Mediated Protein Delivery. Biomacromolecules. 2026;27(8):4955-4971. doi:10.1021/acs.biomac.6c01257
BibTeX
@article{Mei2026,
author = {Mei, Yijun and Cao, Yuanyuan and Mignani, Serge and Majoral, Jean-Pierre and Shen, Mingwu and Shi, Xiangyang},
title = {Phosphorus Dendrimer-Mediated Protein Delivery},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {8},
pages = {4955--4971},
doi = {10.1021/acs.biomac.6c01257}
}
EUVIMED